T-Epivaccines Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

T-Epivaccines General Information


Provider of a cancer therapy based in France. The company develops immunotherapy for lungs and prostate cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Healthcare Services
Primary Office
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

T-Epivaccines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view T-Epivaccines’s complete valuation and funding history, request access »

T-Epivaccines Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
The Institut Pasteur Accelerator/Incubator 000 0000 000000 0
To view T-Epivaccines’s complete investors history, request access »